Development of sarcoidosis in etanercept-treated rheumatoid arthritis patients

By Verschueren Kilian   Essche Els   Verschueren Patrick   Taelman Veerle   Westhovens Rene  

Clinical Rheumatology, Vol. 26, Iss. 11, 2007-11 ,pp. : 1969-1971

Springer Publishing Company

Access to resources Recommend Favorite

Repair of erosions in patients with rheumatoid arthritis treated with etanercept: magnetic resonance imaging findings after 1 year of follow-up

By Lisbona MP   Maymó J   Solano A   Almirall M   Navallas M   Ares J   Carbonell J  

Scandinavian Journal of Rheumatology, Vol. 42, Iss. 6, 2013-11 ,pp. : 437-444

Informa Healthcare

Access to resources Recommend Favorite

Visceral leishmaniasis infection in a patient with rheumatoid arthritis treated with etanercept

By Bagalas V.   Kioumis I.   Argyropoulou P.   Patakas D.  

Clinical Rheumatology, Vol. 26, Iss. 8, 2007-08 ,pp. : 1344-1345

Springer Publishing Company

Access to resources Recommend Favorite

No erosive progression revealed by MRI in rheumatoid arthritis patients treated with etanercept, even in patients with persistent MRI and clinical signs of joint inflammation

By Døhn Uffe   Skjødt Henrik   Hetland Merete   Vestergaard Aage   Møller Jakob   Knudsen Lene   Ejbjerg Bo   Thomsen Henrik   Østergaard Mikkel  

Clinical Rheumatology, Vol. 26, Iss. 11, 2007-11 ,pp. : 1857-1861

Springer Publishing Company

Access to resources Recommend Favorite

Low remission rates but long drug survival in rheumatoid arthritis patients treated with infliximab or etanercept: results from the nationwide Danish DANBIO database

By Østergaard M.   Unkerskov J.   Linde L.   Krogh N. S.   Ravn T.   Ringsdal V. S.   Petri A.   Andersen L. S.   Tarp U.   Hansen A.   Hjardem E.   Hetland M. L.  

Scandinavian Journal of Rheumatology, Vol. 36, Iss. 2, 2007-01 ,pp. : 151-154

Informa Healthcare

Access to resources Recommend Favorite